An interventional study of Diet in Pre Diabetic, sponsored by Muhammad Aron Pase. Not yet recruiting at 1 site in Indonesia. Open to participants aged 25 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-10.
Sponsored by Muhammad Aron Pase · Not applicable, Interventional, and Prevention
Prediabetes is a metabolic condition associated with increased risk of type 2 diabetes and cardiovascular disease. Intermittent fasting (IF) has emerged as a potential dietary intervention to improve metabolic health, yet comparative evidence among different IF patterns remains limited.
This randomized controlled trial aims to evaluate the effects of three intermittent fasting regimens-5:2 fasting, alternate-day fasting, and time-restricted feeding-compared with a control diet on metabolic parameters, inflammatory markers, body composition, and nutrigenomic profiles in adults with prediabetes.
793 studies on the registry are indexed under Glucose Intolerance; 115 are open to participants now.
This study's planned enrollment of 120 is above the median of 56 across 661 interventional studies indexed under Glucose Intolerance.
Browse Glucose Intolerance studies →This is the only study on the registry with Muhammad Aron Pase as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Diet
Behavioral: Diet
Intermittent Fasting
Metabolic Profile
Change in Fasting Plasma Glucose (mg/dL)
Time frame: Baseline, Week 3, and Week 6
Lipid Profile
Concentration Changes of Total Cholesterol
Time frame: Baseline and Week 6
Lipid Profile
Concentration Changes of LDL
Time frame: Baseline and Week 6
Lipid Profile
Concentration Changes of HDL
Time frame: Baseline and Week 6
Lipid Profile
Concentration Changes of Triglycerides
Time frame: Baseline and Week 6
Nutrigenomics
Distribution of Fat Mass and Obesity-Associated gene polymorphism with Enzyme-Linked Immunosorbent Assay method
Time frame: Baseline
Body Composition
Change in BMI
Time frame: Baseline, Week 3, and Week 6
Body Composition
Change in Waist Circumference
Time frame: Baseline, Week 3, and Week 6
Inflammation Profile
Concentration Changes of inflammatory marker (CRP)
Time frame: Baseline and Week 6
Plan to share: Yes — only IPD used in the results publication
Supporting information: Study protocol, Clinical study report
Time frame: 2026-2030
Access criteria: email
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.